Eye on Washington

Article

February is when the administration reveals its detailed plan for the year ahead.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
David Brousseau, MD, highlights impact of timely opioid dosing in pediatric sickle cell pain
August's FDA Focus: Approvals and pipeline updates in pediatrics | Image credit: Contemporary Pediatrics
Related Content
Ibrahim Gwarzo, DrPH, MPH, MBBS | Image credit: Nemours Children's Health

Ibrahim Gwarzo, DrPH, discusses opioid timing, hospitalizations for sickle cell pain

Ibrahim Gwarzo, DrPH, MPH, MBBS;Joshua Fitch, Senior Editor
September 16th 2025
Article
Personalizing Progress: New Data Shaping Care in Central Precocious Puberty

Personalizing Progress: New Data Shaping Care in Central Precocious Puberty

Jill Samis, MD ;Aviva B. Sopher, MD, MS
September 16th 2025
Podcast
FDA expands B-VEC label to include patients from birth with dystrophic epidermolysis bullosa | Image credit: Contemporary Pediatrics

FDA expands B-VEC label to include patients from birth with dystrophic epidermolysis bullosa

Joshua Fitch, Senior Editor
September 16th 2025
Article
Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

September 16th 2025
Podcast
Weekly review: New pediatric pneumococcal data, puzzler, and more

Weekly review: New pediatric pneumococcal data, puzzler, and more

Joshua Fitch, Senior Editor
September 16th 2025
Article
Sudden stop vs tapered adalimumab in IA: Which is best? | Image credit: Contemporary Pediatrics

Sudden stop vs tapered adalimumab in IA: Which is best?

Jon Matthew Farber, MD;Marian Freedman
September 16th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.